Vast Majority of Coronavirus Infections Go Undetected
By HospiMedica International staff writers Posted on 20 Apr 2020 |
A new study suggests that only 6% of SARS-CoV-2 infections worldwide have been identified, and the actual number of infections is in the tens of millions.
Researchers at the University of Göttingen (Germany) used estimates of COVID-19 mortality and time until death from a recent study published in The Lancet Infectious Diseases (DOI: 10.1016/S1473-3099(20)30243-7) to test the quality of official case records issued by countries. On the day of publication, April 8, 2020, the researchers estimated that in Germany alone there were 460,000 infections, instead of the 71,000 reported officially. Using the same estimation technique, the US would have about 10 million cases today, instead of the 533,000 reported, and Spain would have over five million, and not 180,000.
The researchers suggest that insufficient and delayed testing may explain why some European countries, such as Italy and Spain, are experiencing much higher casualty numbers (relative to reported confirmed cases) than Germany, which has detected an estimated 15.6% of infections, compared to only 3.5% in Italy or 1.7% in Spain. Detection rates are even lower in the United States (about 1.6%) and the United Kingdom (1.2%), two countries that have received widespread criticism from public health experts for their delayed response to the pandemic. In contrast, South Korea appears to have discovered almost half of all its SARS-CoV-2 infections.
Based on these methods, the researchers estimate an overall case fatality ratio of 1.4%, much lower than that of the past SARS and MERS epidemics, but still higher than the estimated case fatality ratio for the H1N1 flu epidemic in 2001. Case fatality ratio also varies with the type of patient assessed, such as severe symptomatic versus mild unreported cases. Moreover, in those aged less than 60 years, it is just 0.32%, compared to 6.4% in those aged 60 or more, to 13% in those who are 80 years old or more.
“These results mean that governments and policy-makers need to exercise extreme caution when interpreting case numbers for planning purposes,” said co-lead author professor of development economics Sebastian Vollmer, PhD. “Such extreme differences in the amount and quality of testing carried out in different countries mean that official case records are largely uninformative and do not provide helpful information.”
“Putting an end to current travel restrictions and social distancing measures will not only require a strong reduction in the transmission of new cases, but also major improvements in the ability of countries to detect new infections to then adopt adequate measures for isolating infected patients and tracing potential contact persons,” concluded Professor Vollmer. “In absence of such measures, the virus might remain undetected again for an extended period of time and a new outbreak is likely just a matter of time.”
Related Links:
University of Göttingen
Researchers at the University of Göttingen (Germany) used estimates of COVID-19 mortality and time until death from a recent study published in The Lancet Infectious Diseases (DOI: 10.1016/S1473-3099(20)30243-7) to test the quality of official case records issued by countries. On the day of publication, April 8, 2020, the researchers estimated that in Germany alone there were 460,000 infections, instead of the 71,000 reported officially. Using the same estimation technique, the US would have about 10 million cases today, instead of the 533,000 reported, and Spain would have over five million, and not 180,000.
The researchers suggest that insufficient and delayed testing may explain why some European countries, such as Italy and Spain, are experiencing much higher casualty numbers (relative to reported confirmed cases) than Germany, which has detected an estimated 15.6% of infections, compared to only 3.5% in Italy or 1.7% in Spain. Detection rates are even lower in the United States (about 1.6%) and the United Kingdom (1.2%), two countries that have received widespread criticism from public health experts for their delayed response to the pandemic. In contrast, South Korea appears to have discovered almost half of all its SARS-CoV-2 infections.
Based on these methods, the researchers estimate an overall case fatality ratio of 1.4%, much lower than that of the past SARS and MERS epidemics, but still higher than the estimated case fatality ratio for the H1N1 flu epidemic in 2001. Case fatality ratio also varies with the type of patient assessed, such as severe symptomatic versus mild unreported cases. Moreover, in those aged less than 60 years, it is just 0.32%, compared to 6.4% in those aged 60 or more, to 13% in those who are 80 years old or more.
“These results mean that governments and policy-makers need to exercise extreme caution when interpreting case numbers for planning purposes,” said co-lead author professor of development economics Sebastian Vollmer, PhD. “Such extreme differences in the amount and quality of testing carried out in different countries mean that official case records are largely uninformative and do not provide helpful information.”
“Putting an end to current travel restrictions and social distancing measures will not only require a strong reduction in the transmission of new cases, but also major improvements in the ability of countries to detect new infections to then adopt adequate measures for isolating infected patients and tracing potential contact persons,” concluded Professor Vollmer. “In absence of such measures, the virus might remain undetected again for an extended period of time and a new outbreak is likely just a matter of time.”
Related Links:
University of Göttingen
Latest Critical Care News
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis